Ubi - Profile
✉ Email this page to a colleague
Drugs and US Patents for Ubi
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ubi | DESMOPRESSIN ACETATE | desmopressin acetate | INJECTABLE;INJECTION | 210223-001 | Sep 17, 2020 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ubi | LEUPROLIDE ACETATE | leuprolide acetate | SOLUTION;SUBCUTANEOUS | 217957-001 | Oct 17, 2024 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ubi | DESMOPRESSIN ACETATE | desmopressin acetate | INJECTABLE;INJECTION | 210218-001 | Feb 14, 2020 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ubi | OLANZAPINE | olanzapine | POWDER;INTRAMUSCULAR | 211072-001 | Jun 11, 2025 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ubi | VORICONAZOLE | voriconazole | POWDER;INTRAVENOUS | 211264-001 | Mar 9, 2023 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
